A palladium-catalyzed (3 + 2) cycloaddition between arylalkynes and norbornene derivatives via C–H bond cleavage is reported. This reaction enables the selective synthesis of benzo-fused five-membered cyclic products from a variety of arylalkynes, including electronically biased and alkyl(aryl)alkynes. Notably, the use of a bulky bidentate ligand leads to the (2 + 2) cycloaddition, giving cyclobutene derivatives from the same starting materials. Mechanistic studies indicate that both cycloadditions proceed through hydropalladation of the arylalkynes by Pd(0) and AcOH to generate a vinyl–Pd intermediate. Density functional theory calculations suggest a ligand-to-ligand hydrogen transfer mechanism for this step. The subsequent turnover-determining step is proposed to vary with the ligand environment, involving either C–H bond cleavage or reductive elimination, thereby governing pathway selectivity.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: